TARSONS
Tarsons Products Limited (TARSONS) Stock Analysis
Tarsons Products Limited manufactures laboratory plasticware and scientific consumables for life-science research and diagnostics. Its product range includes pipettes, bottles, filters, and bench-top equipment used in pharma, biotech, and academic labs. The company exports to multiple countries from manufacturing in India. It is listed on Indian stock exchanges.
Healthcare › Medical Instruments & Supplies
₹331.20
+3.19% 1W | +16.20% 52W
Market Cap
1.8k CR
P/E Ratio
158.5
52W High
₹375
52W Low
₹164.4
Div. Yield
0%
Beta
0.3
50 DMA
₹329.2
200 DMA
₹250.7
Profit Margin
2.5%
Inst. Own.
1.6%
🚀 BREAKOUT
🚀 BREAKOUT
Fundamentals
Profit & Loss
| Metric | Dec 2021 | Mar 2022 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 70.66 | 84.94 | 61.79 | 105.72 | 84.80 | 99.25 | 95.68 | 112.69 | 91.36 | 102.33 | 107.89 | 120.93 | 110.24 |
| Expenses | 37.52 | 40.61 | 38.91 | 75.48 | 66.04 | 73.94 | 66.04 | 75.67 | 66.66 | 74.88 | 76.37 | 86.66 | 84.25 |
| Operating Profit | 33.14 | 44.33 | 22.88 | 30.24 | 18.76 | 25.31 | 29.64 | 37.02 | 24.70 | 27.45 | 31.52 | 34.27 | 25.99 |
| OPM % | 46.90% | 52.19% | 37.03% | 28.60% | 22.12% | 25.50% | 30.98% | 32.85% | 27.04% | 26.82% | 29.21% | 28.34% | 23.58% |
| Other Income | 2.46 | 2.58 | 3.24 | 3.38 | 2.91 | 8.43 | 0.85 | 3.78 | 3.34 | 5.80 | 7.07 | 6.83 | 5.98 |
| Interest | 1.37 | 0.45 | 2.51 | 4.25 | 4.32 | 4.84 | 5.03 | 5.20 | 5.07 | 5.18 | 6.05 | 6.25 | 6.27 |
| Depreciation | 5.35 | 7.24 | 10.06 | 12.33 | 11.03 | 14.03 | 17.41 | 20.03 | 19.94 | 22.48 | 25.04 | 29.08 | 27.02 |
| Profit before tax | 28.88 | 39.22 | 13.55 | 17.04 | 6.32 | 14.87 | 8.05 | 15.57 | 3.03 | 5.59 | 7.50 | 5.77 | -1.32 |
| Tax % | 25.66% | 24.89% | 26.72% | 39.50% | 36.39% | 30.80% | 34.66% | 34.49% | 41.25% | 40.61% | 32.93% | 27.56% | 9.09% |
| Net Profit | 21.47 | 29.46 | 9.93 | 10.32 | 4.02 | 10.29 | 5.26 | 10.20 | 1.78 | 3.32 | 5.04 | 4.18 | -1.44 |
| EPS in Rs | 4.04 | 5.54 | 1.87 | 1.94 | 0.76 | 1.93 | 0.99 | 1.92 | 0.33 | 0.62 | 0.95 | 0.79 | -0.27 |
| Metric | Mar 2021 | Mar 2022 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|
| Sales | 229 | 301 | 296 | 392 | 423 | 441 |
| Expenses | 125 | 148 | 196 | 282 | 304 | 322 |
| Operating Profit | 103 | 153 | 100 | 111 | 118 | 119 |
| OPM % | 45% | 51% | 34% | 28% | 28% | 27% |
| Other Income | 5 | 8 | 11 | 16 | 23 | 26 |
| Interest | 3 | 4 | 10 | 20 | 23 | 24 |
| Depreciation | 14 | 22 | 40 | 62 | 97 | 104 |
| Profit before tax | 92 | 135 | 61 | 45 | 22 | 18 |
| Tax % | 25% | 25% | 30% | 34% | 35% | |
| Net Profit | 69 | 101 | 43 | 30 | 14 | 11 |
| EPS in Rs | 12.99 | 18.92 | 8.01 | 5.60 | 2.69 | 2.09 |
| Dividend Payout % | 0% | 0% | 25% | 0% | 0% |
Growth — CAGR
| Metric | 3Y | 5Y | 10Y |
|---|---|---|---|
| Revenue CAGR | – | 13.0% | – |
| Profit CAGR | – | -26.0% | – |
Shareholding Pattern
Promoters47.31%
FIIs5.82%
DIIs0.08%
Public46.79%
Promoters47.30%
FIIs2.46%
Public50.23%
Promoters47.30%
FIIs0.87%
DIIs0.19%
Public51.65%
Promoters47.30%
FIIs0.15%
DIIs0.10%
Public52.44%
Promoters47.30%
FIIs0.55%
DIIs0.61%
Public51.53%
Promoters47.31%
FIIs9.16%
DIIs8.45%
Public35.09%
Promoters47.31%
FIIs8.16%
DIIs0.17%
Public44.36%
Promoters47.31%
FIIs9.53%
DIIs0.30%
Public42.89%
Promoters47.30%
FIIs0.87%
DIIs0.19%
Public51.65%
Promoters47.30%
FIIs0.55%
DIIs0.61%
Public51.53%
TARSONS
Holdings Analysis
Key strengths & risk signals
67
Overall
41
Fundamental
93
Technical
Risks (1)
Cannot calculate PEG - insufficient growth data.
Strengths (3)
BULLISH TREND! 50-day average (329.2) is above 200-day average (250.7) - positive signal.
BREAKOUT! Stock has broken above resistance levels with momentum.
BULLISH SENTIMENT! In last 30 days: 11 up days, 18 down days. Avg volume on up days: 645,623 vs down days: 122,952. Ratio: 5.25x
Fundamental & Technical Analysis
67Overall
41Fundamental
93Technical
Fundamental Breakdown
Growth Quality
13/30
Revenue CAGR: 14.3% (GOOD, 11/15). Profit CAGR: -43.8% (DECLINING, 2/15).
Profit Margin
2/10
LOW MARGIN! 2.5% profit margin - thin profits.
PEG Valuation
1/10
Cannot calculate PEG - insufficient growth data.
Dividend Yield
3/10
NEGLIGIBLE DIVIDEND! 0% yield - little to no income.
Debt to Equity
10/10
VERY LOW DEBT! D/E of 0.00 - excellent financial health.
Public Holding
10/20
SIGNIFICANT PUBLIC HOLDING! 36.67% public ownership - moderate retail influence.
Stability Index
2/10
CAUTION! Company made loss in last quarter. Be careful.
Technical Breakdown
Moving Averages
12/10
BULLISH TREND! 50-day average (329.2) is above 200-day average (250.7) - positive signal.
Price Position
8/10
STRONG POSITION! Current price (331.2) is above both moving averages.
Trend Pattern
20/20
BREAKOUT! Stock has broken above resistance levels with momentum.
52W Performance
6/10
POSITIVE YEAR! Stock gained 16.2% in the last year.
Volume Sentiment
30/30
BULLISH SENTIMENT! In last 30 days: 11 up days, 18 down days. Avg volume on up days: 645,623 vs down days: 122,952. Ratio: 5.25x
RSI
3/5
NEUTRAL! RSI at 51.3 - balanced momentum.
52W Range
4/5
UPPER HALF! Trading at 79.2% of 52W range - positive territory.
Momentum
5/5
STRONG MOMENTUM! Price has grown across all timeframes - up 3.2% (1 week), 9.6% (1 month), 15.2% (3 months). Momentum is accelerating.
Beta
5/5
LOW VOLATILITY! Beta of 0.30 - stable stock, less market risk.
TARSONS
Concall / Investor Presentation
Earnings call transcripts & AI summaries
| Quarter | Concall | Summary |
|---|---|---|
| Q4FY262026-06-01 | Concall PDF | |
| Q3FY262026-02-11 | Concall PDF | |
| Q2FY262025-11-19 | Concall PDF |
Peer Comparison
Healthcare · Medical Instruments & Supplies · 8 stocks
| Stock | Price | P/E | Profit Margin | Revenue CAGR 5Y | Profit CAGR 5Y | 52W Change | Stock Strength | Trendline | YoY Profit | QoQ Profit | YoY Revenue | QoQ Revenue |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| TARSONS | ₹331.20 | 158.5 | 2.5% | 14.3% | -43.8% | +16.2% | 67 | BREAKOUT | -177.8% | -133.3% | +20.6% | -8.9% |
| LAXMIDENTL | ₹184.70 | 32.8 | 10.8% | 19.5% | – | -37.0% | 60 | APPROACHING SUPPORT | +22.6% | +2.0% | +13.5% | +1.1% |
| AGARWALEYE | ₹465.80 | 100.2 | 6.7% | 26.9% | 12.3% | -14.3% | 79 | BREAKDOWN | +50.7% | +13.9% | +26.0% | +8.8% |
| POLYMED | ₹1,593.80 | 51.3 | 15.8% | 19.1% | 22.7% | -16.9% | 65 | APPROACHING SUPPORT | -7.6% | +32.3% | +30.3% | -1.7% |
| LENSKART | ₹646.50 | 178.6 | 6.8% | 35.4% | 67.0% | +59.4% | 60 | BREAKDOWN | +269.1% | +10.7% | +43.3% | +7.9% |
| KRSNAA | ₹533.30 | 18 | 11.6% | 16.6% | 17.8% | -32.4% | 61 | APPROACHING SUPPORT | -19.0% | -60.2% | +22.0% | +22.3% |
| BETA | ₹1,783.00 | 26.3 | 11.1% | 19.2% | 10.5% | -2.7% | 68 | CONSOLIDATING DOWN | +35.0% | +75.6% | +25.2% | +33.5% |
| HESTERBIO | ₹2,236.50 | 13.9 | 41.6% | 7.7% | 27.8% | +25.9% | 77 | BOUNCE FROM SUPPORT | +491.5% | +506.3% | -8.2% | -22.9% |
Data from TradeAlone · Updated daily
No news tagged for TARSONS yet.
